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Blood Transfusion Requirements for Patients on Extracorporeal Membrane
Oxygenation
Min Choi, Hitoshi Hirose MD, PhD*
Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
(*) indicates primary project advisor

Introduction: Extracorporeal membrane oxygenation (ECMO) is a rescue device used
for cardiac and pulmonary dysfunction. Patients on ECMO often require blood
transfusions from bleeding complications. Goals of the study are to determine: 1)
transfusion requirements while on ECMO, 2) incidence of bleeding complications, 3)
transfusion requirements for bleeding complications.
Methods: Packed Red Blood Cell (PRBC) transfusions and bleeding complications
were identified by retrospective chart review of patients on ECMO from 2010 to 2018 at
our institution. Patients were categorized into those who did not bleed (group A) and
those who bled (group B). Site, incidence, and transfusion requirement for each
bleeding event were determined.
Results: Among a total of 217 patients, we identified 62 patients (29%) without bleeding
complications (group A) and 155 patients (71%) with bleeding complications (group B).
PRBC transfusion requirement was higher in group B (1.6 PRBC/day) than group A (0.5
PRBC/day) [p=<0.0001]. In group A, number of PRBC requirements was 0.6 PRBC/day
for VA ECMO (n=42) and 0.2 PRBC/day for VV ECMO (n=20) [p=0.0015]. In group B,
number of PRBC requirements was 1.8 PRBC/day for VA ECMO (n=106) and 1.1

PRBC/day for VV ECMO (n=49) [p=0.0006]. In group B, incidence and number of
PRBC given per major bleeding complication during ECMO were: mediastinal/thoracic
bleed (7.3 PRBC, n=84), GI bleed (7.1 PRBC, n=59), cannulation site bleed (5.2 PRBC,
n=88), and ENT bleed (4.1 PRBC, n=103).
Discussion: Transfusion requirements increased once patients developed bleeding
complications. Patients on VA ECMO required more PRBC/day compared to those on
VV ECMO.

